BiotechTube
Home/Oregon Therapeutics/Grégoire PREVOST
GP

Grégoire PREVOST

CSO

Oregon Therapeutics

Therapeutic Areas

Oncology

Oregon Therapeutics Pipeline

DrugIndicationPhase
XCE853Ovarian Cancer, Advanced Pancreatic CancerPre-clinical

Leadership Team at Oregon Therapeutics

MP
Marc-Henry PITTY
CEO
DC
Denis CARNIATO
CTO
PA
Patrick AMEIL
CFO
View full Oregon Therapeutics profile